Distinguishing between thyroid malignant lymphoma and lymphocytic thyroiditis (Hashimoto's thyroiditis) is quite difficult and problematic. Molecular techniques to detect clonal lymphoid proliferation based on Ig heavy chain (IgH) gene rearrangement may be used to facilitate more accurate diagnosis of malignant lymphoma. We recently established a method for diagnosing thyroid tumors by analyzing ribonucleic acids (RNAs) extracted from the needles used for fine needle aspiration biopsy (aspiration biopsy-RT-PCR). By applying the aspiration biopsy-RT-PCR method to detection of the monoclonality of IgH messenger RNA (mRNA), an accurate molecularbased diagnosis of malignant lymphoma can be established as an adjunct to cytological diagnosis. We first studied RNAs from fresh tissues samples of 8 cases of Hashimoto's thyroiditis and 18 malignant lymphomas to detect the monoclonality of IgH mRNA by seminested RT-PCR. Monoclonality was detected in 8 of 18 (44.4%) malignant lymphomas, but in none of the 8 cases of Hashimoto's thyroiditis. We then studied aspirates from 10 cases of thyroid malignant lymphoma, 4 cases of Hashimoto's thyroiditis, and 1 case each of adenomatous goiter and papillary carcinoma. Monoclonality was detected in the aspirates from 4 of 10 malignant lymphomas (40%), but not from other tissues. Thus, RT-PCR detection of monoclonality of IgH mRNA in addition to cytological examination may be useful in diagnosing thyroid malignant lymphoma. (J Clin Endocrinol Metab 85: [671][672][673][674][675] 2000) P RIMARY THYROID lymphoma (non-Hodgkin's lymphoma) is a rare type of malignant tumor accounting for 2.2-5% of all thyroid cancers and typically occurs in elderly women with a history of lymphocytic thyroiditis (Hashimoto's thyroiditis) (1-6). This tumor originates from B lymphocytes and rarely from T cells (7). The cytological diagnosis of primary malignant lymphoma of the thyroid, particularly high grade lymphoma, is possible by fine needle aspiration biopsy (FNAB) (8, 9); however, the cytological differentiation of Hashimoto's thyroiditis from low grade lymphoma can be problematic due to the lack of marked nuclear atypia. The use of immunotyping with B cell-specific monoclonal antibody (10) or flow cytometry (11) may help to identify clonal populations of lymphoid cells indicative of malignant lymphoma, but accurate, efficient, and less invasive methods of diagnosing thyroid lymphomas other than open biopsy have not been firmly established.
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Recently, PCR had become a viable alternative to the traditional, but more costly and time-consuming, Southern blot hybridization (SBH) analysis for the assessment of Ig heavy chain gene (IgH) rearrangement (B cell monoclonality) (12) (13) (14) . B cell populations from many B cell neoplasms can be readily amplified with a standard approach using a consensus IgH variable region (V H ) framework (FR) III-directed primer, along with a consensus IgH joining region (J H ) primer. The assays have been shown to be very specific, although the overall monoclonality detection rate, or diagnostic sensitivity, is consistently lower than that of Southern hybridization analysis. However, this method cannot be applied to samples obtained by FNAB, because it requires 1 g purified genomic DNA for a successful analysis, which cannot be obtainable by the usual FNAB procedures.
When using only a small number of cells, the analysis of messenger ribonucleic acid (mRNA) is much easier than that of DNA because the copy number of each mRNA is usually larger than that of the corresponding DNA. To establish a method of preoperative molecular-based diagnosis of thyroid cancers, we previously introduced a new technique, aspiration biopsy-RT-PCR (ABRP) (15) . In this technique, RNAs extracted from tumor cells in the needle used for FNAB are used for RT-PCR. ABRP provides additional RNA analysis data to augment the results of cytological diagnosis. The RNA extracted from an FNAB provides sufficient complementary DNA (cDNA) for as many as 20 PCR examinations. We have demonstrated the clinical usefulness of preoperative molecular-based diagnosis by the ABRP detecting oncofetal fibronectin mRNA, the expression of which is restricted in thyroid papillary and anaplastic carcinomas (16 -18) . Further, we also demonstrated that thyroid medullary carcinomas can be successfully preoperatively diagnosed by the ABRP detecting RET protooncogene, calcitonin, and carcinoembryonic antigen (CEA) mRNAs (19) . In this study, to establish a simpler and more rapid diagnosing method, we applied ABRP to the preoperative diagnosis of malignant lymphoma by amplifying IgH cDNA to detect its monoclonality and then attempted to clarify its clinical usefulness. (20) for use in the following study. FNAB samples from 16 thyroid tissues (10 malignant lymphomas, 4 cases of Hashimoto's thyroiditis, and 1 case each of papillary carcinoma and adenomatous goiter) were obtained preoperatively by ABRP as previously described (15) (Table 2). In brief, a syringe with a 22-gauge needle was used to obtain a FNAB from the tissue sample. A sample of the FNAB was prepared on a slide glass for cytological examination, and leftover cells inside the needle were then lysed with a denaturing solution containing 4 mol/L guanidine thiocyanate, 25 mmol/L sodium citrate (pH 7.0), 0.5% sarcosyl, and 0.1 mol/L 2-mercaptoethanol into a 1.5-mL tube. The tubes were then stored at 4 C. Total cellular RNA was extracted as previously described. Whenever possible, the RNA extracted from the whole aspirate was similarly obtained. After surgery or open biopsy, the diagnoses were confirmed histologically. All malignant lymphomas were B cell lymphomas.
Materials and Methods

Extraction of RNAs from the tissue samples and FNABs
Seminested RT-PCR analysis
RT was performed using either the whole RNA extracted by ABRP or 1 g total RNA from tissue samples in a RT mixture containing 50 mmol/L Tris-HCl (pH 8.3), 75 mmol/L KCl, 10 mmol/L dithiothreitol, 3 mmol/L MgCl 2 , 0.5 mmol/L deoxynucleotide triphosphates (dNTPs), 200 U Moloney murine leukemia virus reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD), 2 U/L ribonuclease inhibitor (Takara, Shiga, Japan), and 2.5 mol/L random hexamer (Takara) in a total volume of 20 L at 42 C for 60 min. One microliter of first strand cDNA was used as a template for the seminested PCR reaction with specific primers for IgH cDNA (Fig. 1) . The sequences of the primers are given in Table 3 free water to a final volume of 20 L. The PCR conditions were 95 C for 10 min followed by 15 cycles of denaturation (95 C, 1 min), annealing (60 C, 1 min), then final extension at 72 C for 10 min. The PCR products were separated by 12% PAGE. The gel was stained with SYBR Green I (Takara), and the fluorescence image was analyzed with a Fluor Imager (Molecular Dynamics, Inc., Sunnyvale, CA). The sample, which showed a clearly dominant band by seminested RT-PCR, was determined to be positive for monoclonality. In the case of FNAB, the patients who showed monoclonality in either the leftover cells or the whole aspirate were categorized as positive. One microgram of the RNA extracted from human peripheral blood by Isogen-LS (Wako, Osaka, Japan) was used as a negative control, and 1 g RNA extracted from a B cell lymphoma, which produces a 102-bp band derived from IgH cDNA by RT-PCR, was used as a positive control.
SBH
Southern transfer and prehybridization were performed using a digoxigenin DNA labeling kit and a digoxigenin luminescent detection kit for nucleic acids (Roche Molecular Biochemicals, Tokyo, Japan) according to standard protocols that have been previously described (22) . In brief, 10 g DNA extracted from a tissue sample were digested with BamHI and HindIII. The digests were electrophoresed on an 0.8% agarose gel, transferred to a nylon membrane (Hybond-N ϩ , Amersham Pharmacia Biotech, Tokyo, Japan), and hybridized overnight with a 5.4-kb J H genomic DNA probe (Oncogene Science, Inc., Uniondale, NY) labeled with digoxigenin. After probe hybridization, the membrane was incubated in a blocking solution for 2 h at room temperature. The blocking solution was discarded, and antidigoxigenin antibody conjugated to alkaline phosphatase was added. After appropriate washing, the signal was detected by adding disodium-3-(4-methoxyspirol 1,2-dioxethane-3,2Ј-(5Ј-chloro)tricyclo[3.3. 1.1(3,7) ]decan-4yl)phenyl phosphate (Roche Molecular Biochemicals), and the membrane was then exposed to a radiographic film.
Results
To evaluate the efficiency of the seminested RT-PCR detection of the monoclonality of IgH mRNA, we amplified IgH cDNA by seminested RT-PCR using the tissue samples. Clear monoclonal bands were observed in 8 of 18 (44.4%) malignant lymphomas, but not in the 8 cases of Hashimoto's thyroiditis ( Fig. 2 and Table 1 ). Fifteen malignant lymphomas were subjected to SBH analysis. Monoclonality of the IgH gene was observed in 14 of 16 (87.5%) malignant lymphomas. Next, RNAs obtained by FNAB were amplified by seminested RT-PCR to detect the monoclonality of IgH mRNA ( Fig. 3 and Table 2 ). Monoclonality was positive in 4 of 10 (40%) malignant lymphomas, but was negative in all 4 cases of Hashimoto's thyroiditis as well as the cases of adenomatous goiter and papillary carcinomas. The positive and negative predictive values of this assay were both 100%. In 1 patient, monoclonality was detected only when the whole aspirates were used for the assay. SBH analysis showed monoclonality of the IgH gene in 7 of 9 (77.7%) malignant lymphomas.
Discussion
Most patients with malignant lymphoma note a rapidly growing mass in the neck over a period of 2-3 months, and symptoms of thyroid lymphoma are mainly due to rapid growth of the tumor with compression of the adjacent organs (23) . However, these symptoms often appear in patients with the aggressive inflammation caused by Hashimoto's thyroiditis, and Hashimoto's thyroiditis is believed to be one of the causes of malignant lymphoma. Thus, clinical differentiation between these two conditions is quite difficult, and in most cases a histopathological method by open biopsy is used to confirm the diagnosis. Molecular-based preoperative diagnosis is expected to reduce the invasion to the patients, although there have been only a few studies based on PCR analysis and no studies on RT-PCR analysis of thyroid malignant lymphoma. Lovchik et al. reported a case of malignant lymphoma in which a clonal population of lymphocytes within the FNA specimen was identified using a PCR-based assay for IgH gene rearrangement (24) , but no other report of molecular-based diagnosis of malignant lymphoma using FNABs has been published. This is partly because a malignant lymphoma in the thyroid is a rare tumor, and the fresh tissue or FNAB samples that can be used for RNA analysis are seldom obtainable. In this study we collected RNAs from 18 tissue samples and 10 FNABs obtained from tumors histopathologically diagnosed as malignant lymphoma to estimate the clinical usefulness of detection of the monoclonality of IgH mRNA. In studies of other groups, PCR-based B cell clonality analyses using DNA as the template show a sensitivity and specificity of about 60 -80% and 100%, respectively (25) (26) (27) (28) . In this study using seminested RT-PCR, the specificity was 100%, but the sensitivity using the tissue samples was 44.4%, which is considerably lower than that obtained when using DNA, although the specificity should be more extensively examined in an additional study because only 8 cases of Hashimoto's thyroiditis have been tested. The low expression level of IgH mRNA in malignant lymphoma can be a cause of low sensitivity. However, this does not seem to be likely, because previous studies using immunohistochemistry have detected the expression of Ig in the majority of B cell lymphomas (29, 30) . Before this study, we attempted to detect the monoclonality of IgH cDNA by single RT-PCR. This trial failed, because it often produced many false positive bands that were not derived from IgH cDNAs (data not shown). Thus, we found that when using RNAs, we should choose more restricted RT-PCR amplification conditions to detect a true monoclonal band. Recently, using RT-PCRsingle strand conformation polymorphism, Shiokawa et al. reported a similar sensitivity (50%) in detecting the monoclonality of IgH mRNA in 16 cases of B cell lymphoma (31) . Considering these previously reported results, the low sensitivities in the present study may be a consequence of significant mismatch (i.e. poor sequence homology) between V H primer (FR3A) and the V H -FR III region of a particular B cell lymphoma or a deletion of the terminal 3Ј-bases of this V H -FR III region (32, 33) , because PCR was carried out in more restricted amplification conditions than those in the previous studies. If a modification of this method, in which IgH cDNA is amplified without using a primer annealing to the V H sequence, is possible, it may improve the sensitivity.
In ABRP detection of the monoclonality of IgH mRNA, we have not experienced any false positive results, although only six nonlymphomatous thyroid aspirates have been studied. However, the sensitivity of this method in malignant lymphoma appeared to be almost the same as that using tissue samples (40%). In one case, monoclonality was only detected when the whole aspirate was used for the analysis. In FNAB, much contamination of peripheral blood cells occurs frequently, and the considerable volume of contaminated blood cells may prevent detection of the monoclonality of IgH mRNA. Further, some cases showed discrepant results between ABRP and SBH. This may be at least in a part because the part of the tissue used for SBH was not always the same as that used for aspiration. Thus, in the case of molecular-based diagnosis of malignant lymphoma, multiple examinations by FNAB, as recommended by Hamburger et al. (34) , may be expected to prevent false negative results.
By using combined analyses of molecular and cytological approaches, about half of malignant lymphomas may be diagnosed by FNAB without using more invasive methods, such as open biopsy. Further, the rapid detection of monoclonality of IgH mRNA by RT-PCR, which takes only a half a day, may help cytopathologists to decide whether the patient needs further examination to confirm the diagnosis of malignant lymphoma.
